FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of medicine, particularly ophthalmology, and can be applied to treatment for dystrophy or traumatic erosion of cornea, various keratitis, and chemical burns of conjunctiva and cornea. The ophthalmic ointment includes aecol as active substance, and ingredients in certain ratio: methylcellulose, polyvinyl pyrrolidone, nipagin, and nipazole, as ointment base.
EFFECT: increase in therapeutic efficacy of eye ointment, and reduction of treatment period for eye traumatic injury.
1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EYE OINTMENT | 1994 |
|
RU2094060C1 |
| OCULAR OINTMENT | 1994 |
|
RU2082434C1 |
| MEDICINAL COMPOSITION FOR TREATMENT OF HERPETIC KERATITIS AND KERATOCONJUNCTIVITIS | 1995 |
|
RU2104002C1 |
| REPARATIVE OPHTHALMIC MEDICINAL COMPOSITION | 2009 |
|
RU2402315C2 |
| OPHTHALMIC FILM | 2005 |
|
RU2286170C1 |
| METHOD OF TREATING INFLAMMATORY EYE DISEASES IN HUMAN AND ANIMALS FOR STIMULATION OF REPAIR PROCESSES AND EPITHELISATION | 2011 |
|
RU2470630C1 |
| EYE OINTMENT BASED ON 6-METHYL-3-(THIETAN-3-YL)URACIL WITH WOUND-HEALING EFFECT | 2019 |
|
RU2705392C1 |
| OPHTHALMIC DRUG FILM WITH METHYLURACIL EXHIBITING WOUND HEALING EFFECT | 2020 |
|
RU2740924C1 |
| PHARMACEUTICAL COMPOSITION "OFLOMELID" FOR EXTERNAL APPLICATION IN PYOINFLAMMATORY DISEASE TREATMENT | 2007 |
|
RU2349302C1 |
| DERMAL OINTMENT | 2007 |
|
RU2362568C1 |
